Sequenta Receives $13,000,000 Series B Financing

  • Feed Type
  • Date
    12/8/2010
  • Company Name
    Sequenta
  • Mailing Address
    409 Illinois St. San Francisco, CA 94158
  • Company Description
    Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status.
  • Website
    http://www.sequentainc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $13,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The new funds will be used to continue development and commercialization of molecular diagnostic assays based on a proprietary sequencing approach to the profiling T and B cell receptor repertoires.
  • M&A Terms
  • Venture Investor
    Index Ventures
  • Venture Investor
    Mohr Davidow Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.